This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Nipro Corporation. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations of Yoshikatsu Sugahara in Bone Regeneration
Introduction
Yoshikatsu Sugahara is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of biomedical materials, particularly in bone regeneration. His innovative work has led to the development of a unique bone regeneration material that has the potential to improve surgical outcomes.
Latest Patents
Yoshikatsu Sugahara holds 1 patent for a bone regeneration material. This material comprises a composite of octacalcium phosphate (OCP) particles and gelatin, forming a porous body with multiple pores. The particle size of the OCP particles ranges from 1 μm to less than 1 mm, while the molecular weight of the gelatin is between 30 kDa and 70 kDa. This composition allows the material to resist breakdown during implantation and enhances its handleability.
Career Highlights
Sugahara is associated with Nipro Corporation, a company known for its advancements in medical technology. His work at Nipro has focused on developing innovative solutions that address critical needs in the medical field. His expertise in materials science has positioned him as a key figure in the development of new biomedical products.
Collaborations
Yoshikatsu Sugahara has collaborated with notable colleagues, including Osamu Suzuki and Satoshi Urai. These collaborations have fostered an environment of innovation and have contributed to the advancement of their shared goals in medical technology.
Conclusion
Yoshikatsu Sugahara's contributions to bone regeneration materials exemplify the impact of innovative thinking in the medical field. His work not only enhances surgical practices but also paves the way for future advancements in biomedical materials.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
